 |
 |
|
Are you looking for financial information to benchmark your deal with big pharma? Newly published, PharmaDeals® Deal Making Spotlight Reports catalogue every healthcare deal and alliance entered into by 5 of the top 10 pharmaceutical companies between 2000 and 2005. Buying one or more of these reports not only provides you with in-depth company information but also extended analysis via access to PharmaDeals Agreements and recent articles published in our leading deal making publication PharmaDeals Review. Choose a Deal Making Spotlight on:
|
||
 |
 |
 |
Market News and TrendsDuring March 2006, PharmaDeals Agreements recorded a relatively high number of deals relating to drug delivery, with a total of 24. The majority of these deals were either between start-up and established companies (11 in total) or between two start-up companies (7 in total). In addition to the usual high number of collaborative R&D, licensing, rights and manufacture transactions, three mergers and business acquisitions were announced during March. Of note were five deals that focused upon delivering formulations intransally or through autoinjectors, three transactions involving anticancer products and an agreement to develop a transdermal patch to treat Alzheimer's disease. Read more... |
||
|
|
||
Featured ArticleIontophoretic Topical and Transdermal Drug DeliveryTransdermal delivery has been one of the more successful drug delivery approaches. The 'Patch' is now a household word. This is partly due to the heavy advertisement of nicotine patches, now readily available over the counter. Several other drugs are also on the market in a patch form. All these drugs are small lipophilic molecules. The skin is normally not permeable to water-soluble molecules and permeability of larger water-soluble molecules, such as peptides and proteins, is further limited. In recent years there has been an increasing interest in enhancement technologies that can expand the scope of transdermal delivery to hydrophilic molecules and macromolecules. In this article, Dr Ajay K. Banga (Professor and Chair in the Department of Pharmaceutical Sciences at the Southern School of Pharmacy, Mercer University, Atlanta in Georgia) discusses the potential applications of iontophoresis for topical and transdermal drug delivery. Read more... |
 |
||
|
|
||
 |
Company ProfilesFertin, Innercap, Themis Labs, Valois |
||
|
|
||
Drug Delivery OpportunitiesView all our Drug Delivery Opportunities or alternatively request a password to submit your opportunity online.Featured Opportunity Targeted Microparticles and Nanoparticles Administrative Route - Undisclosed Indication - Lipidated glycosaminoglycan microparticles or nanoparticles, which can encapsulate DNA, proteins and small molecules with high efficiency Licence code - LO-0406-19 |
 |
||
|
|
||
 |
Ensure you receive your copy of the Drug Delivery Report Spring / Summer 2006For deal makers actively assessing drug delivery technology receiving your complimentary copy is a must. The DDR blends high-quality articles covering the latest drug developments in conjunction with concise profiles of companies active in specific technology areas.Apply to receive the next edition of the DDR Find out more about promoting your company |
||
Comprising two specialist areas - PharmaVentures Consulting and PharmaVentures Intelligence - we work with clients to drive greater value from their deals.
If you do not wish to receive DDR E-News in future, please e-mail ddr@pharmamail.biz with the words UNSUBSCRIBE as the subject.
If you do not wish to receive other e-mail communications from PharmaVentures or selected third parties, please e-mail ddr@pharmamail.biz with REMOVE as the subject.
For more details contact
Kate Atherton, Publishing Editor, PharmaVentures Ltd, Magdalen Centre, Oxford Science Park, Oxford OX4 4GA, UK. Tel: +44 (0) 1865 784 177 Fax: +44 (0) 1865 784 178 E-mail ddr@pharmamail.biz